TARGETWATCH
DEDevyser
Siste kurs
65,30 SEK
22.7.2026
Siste
90,00 SEK
+37.83%
Oppside
DVYSR
3 mnd+37,83%1 kursmål
6 mnd+94,49%2 kursmål
1 år+94,49%2 kursmål
Maks+127,41%4 kursmål
Pareto Securities
HelsevesenMedical Devices

Om selskapet

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Yahoo Finance

Siste kursmål

Kursmål
90,00 SEK
Oppside
+37,83%
Siste kurs65,30 SEK

Innsidehandel for Devyser

Kjøp
May 2297K SEKJan WahlströmDaglig leder
Kjøp
May 21190K SEKJan WahlströmDaglig leder

Flere kursmål for Devyser

Dato
Jul 21
Kursmål
90,00 SEK

Analytiker
Dato
Feb 13
Kursmål
164,00 SEK

Analytiker
Dato
Jul -25
Kursmål
190,00 SEK

Analytiker
Dato
Jul -25
Kursmål
150,00 SEK